Please enable JavaScript
Powered by Benchmark MaSS English, Author at Matribhumi Samachar English - Page 279 of 2520
Saturday, January 03 2026 | 03:02:05 AM
Home / MaSS English (page 279)

MaSS English

Ezhou Huahu International Airport Emerges as a Major Air Cargo Hub in China as International Freight Throughput More than Doubles

Ezhou, China–(Newsfile Corp. – November 10, 2025) – Since the beginning of this year, Ezhou Huahu International Airport, has seen robust growth in air cargo. According to the latest data, its international airfreight throughput in the first three quarters rose 138% year-on-year. The airport has also expanded its global cargo …

Read More »

Bengal Energy Announces Fiscal 2026 Second Quarter Results

Calgary, Alberta–(Newsfile Corp. – November 10, 2025) – Bengal Energy Ltd. (TSX: BNG) (“Bengal” or the “Company”) today announces its financial and operating results for the year end and second quarter of fiscal 2026 ended September 30, 2025. SECOND-QUARTER FISCAL 2026 HIGHLIGHTS: The following is an overview of the financial …

Read More »

Tuktu Resources Ltd. Schedules Requisitioned Special Meeting

Calgary, Alberta–(Newsfile Corp. – November 10, 2025) – Tuktu Resources Ltd. (TSXV: TUK) (“Tuktu” or the “Company“), a junior oil and gas producer based in Calgary, Alberta, announces that it has scheduled a special meeting (the “Meeting“) of the Company’s shareholders in response to a requisition from certain shareholders who purport …

Read More »

Sparq Announces AI-Driven Grid Power Control Device

Toronto, Ontario–(Newsfile Corp. – November 10, 2025) – Sparq Systems Inc. (TSXV: SPRQ) (OTCQB: SPRQF) (FSE: M26) (“Sparq” or the “Company“) is pleased to announce that it has developed an AI-driven grid-power control (“GPC“) device for residential, commercial and industrial solar applications. With the rapidly growing solar market, there are …

Read More »

Marvel Biosciences Announces Grant of Deferred Share Units

Calgary, Alberta–(Newsfile Corp. – November 10, 2025) – Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel“), announces the award of 35,697 deferred share units (“DSUs“) to Marvel’s three independent directors, in lieu of cash payment for directors’ fees. The DSUs …

Read More »